Biologics Regulatory Rocket aborts mission to get gene therapy approved by FDA for rare bone marrow disorder byWill SandbergOctober 3, 2025
Biologics New Partnership Brings Next-Generation Cell Isolation Solutions to Researchers Advancing Cell and Gene Therapy Development byNoah SimmonsSeptember 25, 2025
Biologics Spine BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 – an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease byTim AllenJune 13, 2025
Extremities Regulatory Spine Top Stories FDA Grants PMA for the AccelStim Bone Growth Stimulation Device — Expanding Orthofix’s Portfolio of Market-Leading Bone Healing Therapy Solutions byChris StewartMay 4, 2022
Biologics Extremities Financial Bone Therapeutics, Link Health and Pregene to develop and commercialize the ALLOB allogeneic bone cell therapy platform in China and Southeast Asia byJosh SandbergOctober 5, 2020
Sports Medicine Stem cell therapy trial at Sanford first of its kind in U.S. for shoulder injuries byJosh SandbergJanuary 5, 2017
Biologics Apligraf® is First Wound Healing Therapy to Demonstrate Significant Change in Chronic Wound’s Genomic Profile byJosh SandbergJanuary 4, 2017
Hospitals Cytori Cell Therapy Receives Limited Approval for Osteoarthritis in Japan byJosh SandbergJune 27, 2016
Recon Mesoblast Cell Therapy Shows Disease Modifying Effects on Knee Osteoarthritis byJosh SandbergApril 1, 2016
